The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis

Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents our greatest hope to combat the devastating coronavirus disease 2019 (COVID-19) pandemic. Amid ongoing global vaccination efforts, rare cases of severe allergic reactions to COVID-19 mRNA vaccines have receiv...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Allergy Clin Immunol Pract
Hlavní autoři: Shaker, Marcus, Phillips, Elizabeth, Blumenthal, Kimberly G., Abrams, Elissa M., Banerji, Aleena, Oppenheimer, John, Vander Leek, Timothy K., Mack, Douglas P., Wickner, Paige G., Singer, Alexander G., Khan, David A., Greenhawt, Matthew
Médium: Artigo
Jazyk:Inglês
Vydáno: American Academy of Allergy, Asthma & Immunology 2021
Témata:
Review and Feature Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8056986/
https://ncbi.nlm.nih.gov/pubmed/33892171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaip.2021.04.015
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky